Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Safety and Feasibility of an Integrated Fabric-Type Orthosis for Gait and Balance Improvement in Geriatric Patients

12 novembre 2026 mis à jour par: Seoul National University Hospital

Safety and Feasibility of an Integrated Fabric- Type Orthosis With Muscle-Mimicking and Proprioception-Enhancing Functions for Improving Gait and Balance in Geriatric Patients: Pilot Clinical Trial

This pilot clinical trial aims to evaluate the safety and feasibility of an integrated fabric-type orthosis with muscle-mimicking and proprioception-enhancing functions in older adults with geriatric conditions affecting gait and balance. The wearable orthosis provides lower-limb assistance through a fabric-based actuation system and vibrotactile proprioceptive stimulation. Thirty participants aged 65 years or older will undergo gait, balance, proprioception, and electromyography assessments under three conditions: without the orthosis, with the orthosis powered off, and with the orthosis powered on. Outcome measures include gait performance, postural sway, one-leg standing balance, joint position sense, muscle activation, physiological responses, fatigue, and device-related adverse events. The study is designed as an exploratory pilot trial to assess the clinical applicability, usability, and safety of the wearable assistive device in geriatric patients.

Aperçu de l'étude

Type d'étude

Interventionnel

Inscription (Estimé)

30

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

  • Nom: junghyun kim, prof
  • Numéro de téléphone: 82+1088632341
  • E-mail: kiking0@naver.com

Lieux d'étude

    • Jongno
      • Seoul, Jongno, Corée du Sud, 03080
        • Recrutement
        • Seoul National University Hospital
        • Contact:

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

65 ans et plus (Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

Eligibility for participation in the study requires that all the following criteria are met:

  1. Age: Participants must be 65 years of age or older.

  2. Comprehension and Compliance: Able to fully understand and comply with the instructions and study procedures.

  3. Mobility-Impacting Conditions: Must have at least one of the following conditions affecting mobility: (1)Sarcopenia:

    • Muscle Strength: Handgrip strength of <28 kg for men and <18 kg for women.
    • Muscle Function: Short Physical Performance Battery (SPPB) score of 8 or less.
    • Muscle Mass: Bioelectrical impedance analysis (BIA) showing muscle mass <7.0 kg/m² for men and <5.7 kg/m² for women. (2)Diabetes:
    • Diagnosed distal symmetric polyneuropathy.
    • Sensory impairments in toes or feet. (3)Knee Osteoarthritis:
    • Kellgren-Lawrence grade ≥2.
    • Persistent pain (≥3 months) with a severity of at least 3 on the Numerical Rating Scale (NRS).

Exclusion Criteria:

Individuals meeting any of the following criteria will be excluded from study participation:

  1. Inability to Consent: Unable to provide informed consent or not willing to participate in the study procedures.

  2. Severe Sensory or Motion Limitations: Including severe visual or vestibular impairments that could increase the risk of falling.

  3. Communication Barriers: Significant hearing, speech, or language problems that would hinder communication with study personnel.

  4. Independent Walking Inability: Cannot walk independently without the aid of a walking device.

  5. Other Significant Diseases or Conditions:

    • Neurological disorders that affect walking ability (e.g., stroke, Parkinson's disease).
    • Orthopedic or musculoskeletal conditions severely affecting lower limb function.
    • Severe cardiovascular conditions including uncontrolled hypertension or heart failure.
    • Respiratory diseases requiring regular oxygen therapy.
    • Active cancer treatment or cancer treatment within the past 3 years (except basal cell carcinoma or localized prostate cancer).
    • Severe psychiatric disorders like schizophrenia or bipolar disorder.
  6. Other Exclusionary Factors:

    • Past severe orthopedic surgeries on lower limbs which might affect gait and mobility.
    • Severe back pain or any other condition affecting mobility not already listed.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Autre
  • Répartition: N / A
  • Modèle interventionnel: Affectation à un seul groupe
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Integrated Fabric-Type Orthosis Evaluation

Participants will undergo gait, balance, proprioception, and electromyography assessments under three conditions: without the orthosis, with the orthosis powered off, and with the orthosis powered on. The wearable fabric-type orthosis provides muscle-mimicking lower-limb assistance and proprioception-enhancing vibrotactile stimulation for gait and balance support in older adults.

A wearable fabric-type lower-limb orthosis integrating muscle-mimicking actuation and proprioception-enhancing vibrotactile stimulation. The device is designed to assist knee and ankle movements during gait and balance activities in older adults with gait and balance impairments. Participants will be evaluated under three conditions: without the orthosis, with the orthosis powered off, and with the orthosis powered on.

Autres noms:
  • Soft Exosuit

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Change in Blood Pressure From Before to After Functional Assessment
Délai: Immediately before and after the functional assessment at each study visit

Systolic and Diastolic blood pressure will be measured in millimeters of mercury (mmHg) before and after completion of the functional assessment, which includes gait and balance tests performed under the designated orthosis conditions.

Immediately before and after the functional assessment at each study visit
Change in Heart Rate From Before to After Functional Assessment
Délai: Immediately before and after the functional assessment at each study visit

Heart rate will be measured in beats per minute (bpm) before and after completion of the functional assessment, which includes gait and balance tests performed under the designated orthosis conditions.

Immediately before and after the functional assessment at each study visit
Change in Perceived Exertion From Before to After Functional Assessment
Délai: Immediately before and after the functional assessment at each study visit

Perceived exertion will be assessed using the Borg Scale before and after completion of the functional assessment. Higher scores indicate greater perceived exertion.

Immediately before and after the functional assessment at each study visit
Change in Pain Intensity From Before to After Functional Assessment
Délai: Immediately before and after the functional assessment at each study visit

Pain intensity will be assessed using the Numeric Rating Scale (NRS) before and after completion of the functional assessment. Scores range from 0 to 10, with higher scores indicating greater pain intensity.

Immediately before and after the functional assessment at each study visit

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
6-Minute Walk Test
Délai: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To evaluate walking endurance and functional mobility by measuring the maximum walking distance achieved within six minutes.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
10-Meter Walk Test
Délai: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To assess gait speed and short-distance walking performance under different orthosis conditions.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
20-Meter Walk Test
Délai: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To assess walking speed and gait performance over a longer walking distance.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Surface Electromyography
Délai: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To evaluate lower-limb muscle activation patterns during walking using surface electromyography (sEMG).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Static One-Leg Standing Balance Test
Délai: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To evaluate static balance ability by measuring the duration participants can maintain single-leg standing.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Postural Sway
Délai: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To assess postural stability during quiet standing using center of pressure (COP)-based balance measurements.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Passive Joint Position Reproduction Test
Délai: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To evaluate proprioceptive accuracy by measuring passive knee joint position reproduction error.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Active Joint Position Reproduction Test
Délai: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To evaluate proprioceptive accuracy by measuring active knee joint position reproduction error.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Participant Satisfaction
Délai: Immediately post-brace activation (power on)

To assess participant satisfaction, comfort, perceived usability, and overall acceptance of the wearable orthosis.

Immediately post-brace activation (power on)
Gait Speed
Délai: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Gait speed measured using the GAITRite system, reported in meters per second (m/s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Cadence
Délai: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Cadence measured using the GAITRite system, reported in steps per minute (steps/min).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Step Time
Délai: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Step time measured using the GAITRite system, reported in seconds (s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Step Length
Délai: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Step length measured using the GAITRite system, reported in centimeters (cm).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Stride Time
Délai: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Stride time measured using the GAITRite system, reported in seconds (s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Stride Length
Délai: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Stride length measured using the GAITRite system, reported in centimeters (cm).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Single Support Time
Délai: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Single support time measured using the GAITRite system, reported in seconds (s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Double Support Time
Délai: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Double support time measured using the GAITRite system, reported in seconds (s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Stance Time
Délai: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Stance time measured using the GAITRite system, reported in seconds (s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Swing Time
Délai: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Swing time measured using the GAITRite system, reported in seconds (s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Directeur d'études: hyungik shin, prof, Seoul National University Hospital

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

17 juin 2026

Achèvement primaire (Estimé)

31 décembre 2027

Achèvement de l'étude (Estimé)

31 décembre 2027

Dates d'inscription aux études

Première soumission

21 mai 2026

Première soumission répondant aux critères de contrôle qualité

12 novembre 2026

Première publication (Réel)

18 novembre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

18 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

12 novembre 2026

Dernière vérification

1 mai 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner